文献速递肿瘤 PET/CT核素与放射性配体治疗放射性药物与辐射防护

炎症性肠病的分子影像

Molecular Imaging in Inflammatory Bowel Disease.
PubMed 文献 · Semin Nucl Med · 2023-01-25

炎症性肠病(IBD)包括溃疡性结肠炎和克罗恩病,核医学技术如99mTc-HMPAO自体标记白细胞闪烁显像(WBCS)和PET/CT在其管理中发挥作用。WBCS高度敏感且准确,正常扫描可排除活动性IBD,并可用于评估病变范围和严重程度及治疗反应。18F-FDG PET/CT对活动性肠道炎症检测敏感性极佳但部分研究特异性差,PET单独评估溃疡性结肠炎似已足够而PET/CT对克罗恩病提供更多信息。

要点

  • WBCS高度敏感且准确,正常扫描可排除活动性IBD,可用于评估病变范围、严重程度及治疗反应。
  • 18F-FDG PET/CT检测活动性肠道炎症敏感性极佳但部分研究特异性差,PET单独评估溃疡性结肠炎似已足够。
  • PET可用于IBD早期评估,尤其不能耐受结肠镜等侵入性检查的儿童。

核心结论

  • 核医学技术不是IBD检查的首选,超声和磁共振(无辐射)可能是首选,诊断通常由内镜活检确立。
  • WBCS高度敏感且准确,当其他方法因任何原因无法使用时是真正的选择,正常扫描可排除活动性IBD。
  • 18F-FDG PET/CT在儿童和成人中检测活动性肠道炎症敏感性极佳但部分研究特异性差,PET单独评估溃疡性结肠炎似已足够,而PET/CT评估克罗恩病比PET单独提供更多信息。
  • 许多问题尚待解答,但PET似乎是IBD无创评估有前景的工具;PET/MR在不久的将来可能成为评估IBD患者的有力工具。
  • 针对固有免疫标志物的抗体免疫PET也正在研究中用于检测结肠炎症,这些技术在人体中的发展可能提供比内镜侵入性更低的诊断和监测IBD的方法。

研究设计与样本

  • 本文为综述,未报告系统检索范围。

主要发现

  • 白细胞可在体外标记(欧洲使用99mTc-HMPAO,美国使用111In-oxine)或使用抗粒细胞单克隆抗体在体内标记。
  • WBCS高度敏感且准确,正常扫描可排除活动性IBD,并可用于测量病变范围和严重程度及评估治疗反应。
  • 18F-FDG PET/CT在儿童和成人中检测活动性肠道炎症显示极佳敏感性,但部分研究特异性差。
  • PET单独评估溃疡性结肠炎似已足够,但PET/CT在克罗恩病评估中比PET单独提供相当多的额外信息。
  • PET在IBD的当前临床应用包括用于IBD早期评估,尤其是可能无法耐受结肠镜等侵入性检查的儿童。

关键数值与推荐

  • IBD的诊断通常由内镜活检确立,超声和磁共振(无辐射)可能是首选的检查方法。
  • WBCS正常扫描可排除活动性IBD的存在。
  • 18F-FDG PET/CT检测活动性肠道炎症敏感性极佳但部分研究特异性差。

临床怎么用

  • 核医学技术不是IBD检查的首选,超声和磁共振(无辐射)可能是首选,诊断通常由内镜活检确立。
  • WBCS高度敏感且准确,当其他方法因任何原因无法使用时是真正的选择,正常扫描可排除活动性IBD。
  • PET可用于IBD早期评估,尤其不能耐受结肠镜等侵入性检查的儿童;作者认为PET似乎是IBD无创评估有前景的工具。

局限性

  • 18F-FDG PET/CT在部分研究中特异性差。
  • 许多问题尚待解答。
  • PET/MR在不久的将来可能成为评估IBD患者的有力工具,免疫PET等仍在研究中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammatory bowel diseases (IBD) are chronic immune-mediated inflammatory diseases affecting the gastrointestinal tract. Classically, two subtypes of IBD are recognized: Ulcerative colitis and Crohn's disease. There is not a single and reliable test for IBD diagnosis but the nuclear medicine techniques like 99mTc-HMPAO autologous labelled leukocytes scintigraphy (WBCS) and PET/CT plays a role in the management of IBD. Leukocytes can be labelled "in vitro" (using 99mTc-HMPAO in Europe or 111In-oxine in America) or "in vivo" using antigranulocyte monoclonal antibodies. Nuclear medicine techniques are not the first choice to investigate IBD. Ultrasonography and magnetic resonance (radiation free) are probably the first option, and the diagnosis is commonly established by endoscopic biopsies. Nevertheless, WBCS is highly sensitive and accurate and represent a real option when other methods cannot used for whatever reason. In fact, a normal scan discards the presence of active IBD. The test is also useful to measure the extension and severity of the diseases and to evaluate the response to treatment. PET/CT imaging using 18F-FDG has recently been introduced and studied in both children and adults showing an excellent sensitivity for detecting active intestinal inflammation, but poor specificity in some studies. PET alone appears to be sufficient for the evaluation of ulcerative colitis, but PET/CT provides considerably more information than PET alone in the evaluation of Crohn's disease. Current clinical applications of PET in IBD include its use in the early evaluation of IBD, especially in children who may not tolerate an invasive test such as colonoscopy. Many questions remain to be answered, but PET appears to be a promising tool in the non-invasive evaluation of IBD. On the other hand, PET/MR could become in the near future a powerful tool in the evaluation of IBD patients. In addition, immuno-PET with antibodies targeting innate immune markers is also being investigated to detect colonic inflammation. The development of these technologies in humans could offer a less invasive method than endoscopy for the diagnosis and monitoring of IBD.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Noriega-Álvarez E, Martín-Comín J. Molecular Imaging in Inflammatory Bowel Disease. Semin Nucl Med. 2023. PMID: 36702729. doi:10.1053/j.semnuclmed.2022.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。